Navigating the CKD Drugs Market: SGLT2 Inhibitors, Non-Steroidal...

added blog Shopping

2026-08-24 05:51:51 -

Navigating the CKD Drugs Market: SGLT2 Inhibitors, Non-Steroidal MRAs, and Renal Anemia Therapies to 2032

Global Chronic Kidney Disease (CKD) Drugs Market Set to Surpass USD 22.56 Billion by 2032 as Cardiorenal-Metabolic Therapies and Disease-Modifying Breakthroughs Reshape Nephrology PUNE, INDIA — The global clinical nephrology landscape is witnessing a foundational transition from symptomatic, late-stage disease management toward early, proactive disease modification. According to a...

0 Comments 0 Shares 13 Views 0 Reviews